Segment Information (Details) - USD ($) |
3 Months Ended | 9 Months Ended | |||
|---|---|---|---|---|---|
Sep. 30, 2018 |
Sep. 30, 2017 |
Sep. 30, 2018 |
Sep. 30, 2017 |
Dec. 31, 2017 |
|
| Segment Reporting Information [Line Items] | |||||
| Net sales | $ 77,792,878 | $ 54,595,924 | $ 208,167,243 | $ 148,310,548 | |
| Operating income (loss) | 7,532,371 | (1,767,809) | 17,735,367 | 815,640 | |
| Acquisition related costs | 180,671 | 37,402 | 870,888 | 782,397 | |
| Earn-out adjustments | (269,083) | 62,804 | 2,192,574 | 145,200 | |
| Interest expense | 585,888 | 279,598 | 1,303,724 | 715,131 | |
| Change in fair value of interest rate swaps | (7,490) | (8,497) | (99,948) | (33,000) | |
| Other loss (income), net | 493,413 | (316,158) | 522,598 | (316,158) | |
| Income before income taxes | 6,460,560 | (1,722,752) | 16,008,993 | 449,667 | |
| Identifiable assets | 240,363,137 | 240,363,137 | $ 159,874,150 | ||
| Goodwill | 9,548,992 | 9,548,992 | 6,003,525 | ||
| Operating segment | |||||
| Segment Reporting Information [Line Items] | |||||
| Net sales | 77,792,878 | 54,595,924 | 208,167,243 | 148,310,548 | |
| Operating segment | Metals Segment | |||||
| Segment Reporting Information [Line Items] | |||||
| Net sales | 61,024,373 | 43,022,833 | 162,891,099 | 111,821,115 | |
| Operating income (loss) | 7,984,117 | (1,263,900) | 23,091,164 | 2,659,666 | |
| Identifiable assets | 199,390,326 | 199,390,326 | 130,456,857 | ||
| Goodwill | 8,194,262 | 8,194,262 | 4,648,795 | ||
| Operating segment | Specialty Chemicals Segment | |||||
| Segment Reporting Information [Line Items] | |||||
| Net sales | 16,768,505 | 11,573,091 | 45,276,144 | 36,489,433 | |
| Operating income (loss) | 1,354,617 | 1,150,661 | 3,324,778 | 3,796,032 | |
| Identifiable assets | 31,109,653 | 31,109,653 | 25,394,078 | ||
| Goodwill | 1,354,730 | 1,354,730 | 1,354,730 | ||
| Corporate | |||||
| Segment Reporting Information [Line Items] | |||||
| Unallocated corporate expenses | 1,894,775 | 1,554,364 | 5,617,113 | 4,712,461 | |
| Identifiable assets | 9,863,158 | 9,863,158 | $ 4,023,215 | ||
| Segment reconciling items | |||||
| Segment Reporting Information [Line Items] | |||||
| Acquisition related costs | 180,671 | 37,402 | 870,888 | 782,397 | |
| Earn-out adjustments | (269,083) | 62,804 | 2,192,574 | 145,200 | |
| Interest expense | 585,888 | 279,598 | 1,303,724 | 715,131 | |
| Change in fair value of interest rate swaps | (7,490) | (8,497) | (99,948) | (33,000) | |
| Other loss (income), net | $ 493,413 | $ (316,158) | $ 522,598 | $ (316,158) | |
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|